4//SEC Filing
Dolski Robert 4
Accession 0000899243-22-003633
CIK 0001651431other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:05 PM ET
Size
5.6 KB
Accession
0000899243-22-003633
Insider Transaction Report
Form 4
Dolski Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+101,180→ 101,180 totalExercise: $2.05Exp: 2032-01-26→ Common Stock (101,180 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on January 27, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Checkmate Pharmaceuticals, Inc.
CIK 0001651431
Entity typeother
Related Parties
1- filerCIK 0001840408
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:05 PM ET
- Size
- 5.6 KB